COMMUNIQUÉS West-GlobeNewswire

Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference
26/11/2025
PITTSBURGH, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 8 th Annual Evercore Healthcare Conference on December 3, 2025 [...]
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
26/11/2025
Adoption of LIBERTY is Consistent with Emory’s Commitment to the Growing and Evolving Field of Interventional Radiology HINGHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer [...]
TOMI Environmental Solutions Announces $3 Million Custom Integration Pipeline with Strategic Life Sciences Partnerships
26/11/2025
FREDERICK, Md., Nov. 26, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announces substantial progress in its custom integration pipeline, currently valued at approximately $3 million, [...]
FibroBiologics Announces Payoff of Outstanding Debt
26/11/2025
Repayment of convertible promissory notes strengthens balance sheet and eliminates further dilution from conversions HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth
26/11/2025
THE WOODLANDS, TX, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Moleculin Announces Reverse Stock Split
26/11/2025
HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation [...]
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty
26/11/2025
WALTHAM, Mass. and DUBLIN, Ireland, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA) (“ Mural ”) announces that, in accordance with the terms of the transaction agreement between XOMA Royalty [...]
Avis aux médias: L’Hôpital Shriners pour enfants Canada ouvre ses portes au public le 29 novembre pour souligner son 100e anniversaire
26/11/2025
MONTRÉAL, 26 nov. 2025 (GLOBE NEWSWIRE) -- Quoi : Dans le cadre des célébrations de son centenaire, l’Hôpital Shriners pour enfants Canada invite les familles à prendre part à une journée portes ouvertes qui allie [...]
Media advisory: Shriners Hospitals for Children Canada Opens Its Doors to the Public on November 29 in Honour of Its 100th Anniversary
26/11/2025
MONTREAL, Nov. 26, 2025 (GLOBE NEWSWIRE) -- What: Families looking for an educational and fun weekend activity are invited to discover Shriners Hospitals for Children Canada during its Open House. Children can enjoy [...]
Moleculin to Participate in the Virtual Investor Closing Bell Series
26/11/2025
Live video webcast with Walter Klemp, Chairman and Chief Executive Officer, on Tuesday, December 2 nd at 4:00 PM ET HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the [...]
Wake Radiology Moves its Chapel Hill Office to the Timberlyne Neighborhood
26/11/2025
New footprint offers a modern, conveniently accessible facility primed for continued office growth RALEIGH, N.C., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex, the largest outpatient imaging provider [...]
First Rate Infusion & Wellness Launches Mobile “Vitamins in a Bag” Program to Support Employee Wellness Across Dallas–Fort Worth
26/11/2025
First Rate Infusion & Wellness Expands Services With Mobile IV Hydration Offering for Employers in the Dallas–Fort Worth Region Mesquite, Texas, Nov. 26, 2025 (GLOBE NEWSWIRE) -- First Rate Infusion & Wellness, [...]
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
26/11/2025
RESEARCH TRIANGLE PARK, N.C., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will [...]
Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.
26/11/2025
Scilex closed the second tranche, purchasing a pre-funded warrant exercisable for 263,914,094 shares of Datavault AI Inc. (Nasdaq: DVLT; “Datavault AI”) common stock in Bitcoin (BTC) (based on the spot exchange rate of [...]
Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025
26/11/2025
TUCSON, Ariz., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved [...]
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
26/11/2025
BOSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Adam Crystal, M.D., Ph.D., President of Research & Development at Tango Therapeutics, is scheduled to [...]
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference
26/11/2025
NEW HAVEN, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Noah [...]
CG Oncology Announces New Board Member and Board Transition
26/11/2025
- Appoints Accomplished Life Sciences Executive Christina Rossi to its Board of Directors - IRVINE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical [...]
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
26/11/2025
Key step achieved in advancing HER-096 towards Phase 2 efficacy trial Espoo, Finland, 26 November 2025: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the [...]

Pages